ArticleRadiology case reports2026
Reframing the arteriovenous malformation paradigm: A case supporting conservative management of enhanced myometrial vascularity after uterine instrumentation.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The diagnostic term acquired uterine arteriovenous malformation has come under scrutiny in the last several years as we learn more about the pathophysiology of uterine vasculature remodeling associated with pregnancy. The newer diagnostic term enhanced myometrial vascularity describes the ultrasonographic features that are seen in the myometrium surrounding pregnancy. As the terminology evolves, so too should our treatment. This case of a 32-year-old G2P1011 presenting with enhanced myometrial vascularity 3 months after dilation and evacuation for a second trimester twin pregnancy loss advocates for a conservative approach to treatment while avoiding the risks of the conventional treatment of uterine artery embolization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.